ISRCTN86495943
Completed
未知
Personalized diet intervention to treat fatty liver and visceral adiposity
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Overweight, non-alcoholic fatty liver disease
- Sponsor
- Academy of Finland
- Enrollment
- 49
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
2023 Interim results article in https://doi.org/10.1128/mbio.02663-22 (added 20/06/2024)
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Age 18\<75 years
- •2\. Being overweight (body mass index \[BMI] \>25 kg/m²
- •3\. High waist circumference (\>102 cm for males, \>88 cm for females)
Exclusion Criteria
- •1\. Antibiotic treatment 1 month prior to the study
- •2\. Excessive alcohol consumption (\>20 g/day for females, 30 g/day for males)
- •3\. Inflammatory bowel disease
- •4\. Celiac disease
- •5\. Major eating disorders
- •6\. Hypothyroidism
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Not Applicable
Weight Loss Diet in Obesity With Metabolic SyndromeObesityDiet ModificationNCT03558685Tel-Aviv Sourasky Medical Center120
Completed
Not Applicable
Liver Fat as a Dietary Target for Treating Cardiometabolic Disorders in Prediabetes and Type 2 DiabetesNAFLDDiabetes Mellitus, Type 2PreDiabetesNCT04527965Uppsala University150
Completed
Not Applicable
Does the presence or absence of the gene for PNPLA3 affect response to a change in diet in people with non-alcoholic fatty liver disease (NAFLD)?on-alcoholic fatty liver disease (NAFLD)Digestive SystemISRCTN93410321ewcastle upon Tyne Hospitals NHS Foundation Trust49
Recruiting
Not Applicable
Dairy Lipids and Cardiometabolic RiskMorbid ObesityNCT05783466Hospices Civils de Lyon75
Recruiting
Phase 4
Phenotype-Tailored Lifestyle Intervention for Obesity: A Randomized TrialObesityNCT06770049Mayo Clinic228